Eradication of Hepatitis C Virus in a Kidney Transplant Patient
Author Information
Author(s): Chang Ming-Ling, Lai Ping-Chin, Yeh Chau-Ting
Primary Institution: Chang Gung Memorial Hospital
Hypothesis
Can low-dose long-term interferon therapy effectively eradicate hepatitis C virus in renal transplant recipients with dual hepatitis B and C infections?
Conclusion
Low-dose, long-term interferon therapy may achieve sustained eradication of HCV in renal transplant recipients with dual HBV and HCV infections.
Supporting Evidence
- The patient had dual infections with HBV and HCV prior to renal transplantation.
- His HCV was successfully eradicated after three and a half years of antiviral therapy.
- There were no episodes of allograft rejection during the treatment.
Takeaway
A man with both hepatitis B and C got better after taking a special medicine for a long time, and now he doesn't have the virus anymore.
Methodology
The patient received low-dose interferon and ribavirin therapy for three and a half years.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
51-year-old Taiwanese man.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website